We conclude that inhibition of ceramide biosynthesis protects against diet-induced NAFLD and atherosclerosis in LDLR-/- mice by reducing insulin resistance, suppressing de novo lipogenesis, and enhancing HDL biogenesis and turnover. Here, LDLR is linked to Insulin resistance.